Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2002-5-7
pubmed:abstractText
TNF-alpha is a cytokine associated with inflammatory diseases, including asthma. Increased levels of TNF-alpha were found in the bronchoalveolar lavage fluid of mice undergoing a dinitrofluorobenzene (DNFB)-induced non-IgE-mediated pulmonary hypersensitivity reaction. We report in this work that TNF-alpha increases the susceptibility of sensory neurons to dinitrobenzene sulfonic acid (DNS) and capsaicin, leading to a tracheal vascular hyperpermeability response in DNFB-sensitized and DNS-challenged mice. mAb against TNF-alpha or the TNFR1 inhibited this hyperpermeability response in DNFB-sensitized and DNS-challenged mice. Furthermore, the hyperpermeability response after DNS challenge was abolished in DNFB-sensitized mast cell-deficient WBB6F(1)-W/W(V) mice. These animals showed a remarked decrease of TNF-alpha bronchoalveolar lavage fluid levels after a single DNS challenge. The hyperpermeability response after DNS challenge was regained in mast cell-deficient mice after mast cell reconstitution. These findings indicate a prominent role for TNF-alpha and its TNFR1 in the DNFB-induced tracheal hyperpermeability response. We propose that a priming effect of mast cell-derived TNF-alpha on the sensory neurons could be the mechanism of action of TNF-alpha in the vascular hyperpermeability response in tracheas of mice undergoing a pulmonary hypersensitivity reaction.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Benzenesulfonates, http://linkedlifedata.com/resource/pubmed/chemical/Capsaicin, http://linkedlifedata.com/resource/pubmed/chemical/Dinitrofluorobenzene, http://linkedlifedata.com/resource/pubmed/chemical/Haptens, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor..., http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor..., http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/dinitrobenzenesulfonic acid
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
168
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5297-302
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11994487-Administration, Topical, pubmed-meshheading:11994487-Animals, pubmed-meshheading:11994487-Antibodies, Monoclonal, pubmed-meshheading:11994487-Antigens, CD, pubmed-meshheading:11994487-Benzenesulfonates, pubmed-meshheading:11994487-Bronchoalveolar Lavage Fluid, pubmed-meshheading:11994487-Capillary Permeability, pubmed-meshheading:11994487-Capsaicin, pubmed-meshheading:11994487-Dinitrofluorobenzene, pubmed-meshheading:11994487-Haptens, pubmed-meshheading:11994487-Immunization, Secondary, pubmed-meshheading:11994487-Injections, Intravenous, pubmed-meshheading:11994487-Male, pubmed-meshheading:11994487-Mast Cells, pubmed-meshheading:11994487-Mice, pubmed-meshheading:11994487-Mice, Inbred BALB C, pubmed-meshheading:11994487-Mice, Mutant Strains, pubmed-meshheading:11994487-Nerve Endings, pubmed-meshheading:11994487-Neurons, Afferent, pubmed-meshheading:11994487-Receptors, Tumor Necrosis Factor, pubmed-meshheading:11994487-Receptors, Tumor Necrosis Factor, Type I, pubmed-meshheading:11994487-Receptors, Tumor Necrosis Factor, Type II, pubmed-meshheading:11994487-Respiratory Hypersensitivity, pubmed-meshheading:11994487-Trachea, pubmed-meshheading:11994487-Tumor Necrosis Factor-alpha
pubmed:year
2002
pubmed:articleTitle
Mast cell-derived TNF-alpha primes sensory nerve endings in a pulmonary hypersensitivity reaction.
pubmed:affiliation
Department of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, The Netherlands. A.H.vanHouwelingen@pharm.uu.nl
pubmed:publicationType
Journal Article